BioSpace News Archive

Transgene’s Combined General Meeting of May 5, 2023

The Combined Ordinary and Extraordinary General Meeting of Transgene’s shareholders was held at 9:00 a.m. at the Company’s headquarters.

May 5, 2023
·
4 min read
Deals

TTG Imaging Solutions Acquires Digirad Health from Star Equity Holdings

TTG Imaging Solutions, LLC announced the acquisition of Digirad Health, Inc., headquartered in Suwanee, GA. The acquisition closed on May 4, 2023.

May 5, 2023
·
3 min read
Business

Amador Bioscience Welcomes Dr. Lorin Roskos as Chief Scientific Officer and President of Quantitative Clinical Pharmacology

Amador Bioscience has announced the appointment of Dr. Lorin Roskos as Chief Scientific Officer (CSO) and President of Quantitative Clinical Pharmacology (QCP).

May 5, 2023
·
2 min read
Business

Evolus to Report First Quarter 2023 Results and Provide Business Update

Evolus, Inc. today announced that it will report its first quarter 2023 financial results and provide a business update on Tuesday, May 9, 2023, after the U.S. financial markets close.

May 5, 2023
·
1 min read
Policy

Nexus Pharmaceuticals, Inc. Receives Successful FDA Inspection of Pharmaceutical Manufacturing Facility in Pleasant Prairie, Wisconsin

Nexus Pharmaceuticals, Inc. announced that its pharmaceutical manufacturing facility in Pleasant Prairie, Wisconsin, was successfully inspected by the Food and Drug Administration, which will allow Nexus to begin commercial operations.

May 5, 2023
·
2 min read
Deals

NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

NeuroOne Medical Technologies today announced that, effective May 1, 2023, the Compensation Committee of the Board of Directors approved an equity award under the NeuroOne Medical Technologies Corporation 2021 Inducement Plan.

May 5, 2023
·
1 min read
Policy

FDA Roundup: May 05, 2023

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

May 5, 2023
·
3 min read
Policy

Zoetis Announces U.S. FDA Approval of Librela™ (bedinvetmab injection) to Control Osteoarthritis (OA) Pain in Dogs

Zoetis Inc. announced that the U.S. Food and Drug Administration has approved Librela™ for the control of pain associated with osteoarthritis in dogs.

May 5, 2023
·
9 min read
Galapagos creates new subscription right plans - May 05, 2023

Galapagos NV announced that its Board of Directors created 1,975,000subscription rights under new subscription rightplans for the benefit of certain members ofthe personnelof the company and its subsidiaries.

May 5, 2023
·
3 min read
Deals

Rhythm Pharmaceuticals Announces New Employment Inducement Grants - May 5, 2023

Rhythm Pharmaceuticals, Inc. today announced that on May 2, 2023, the Compensation Committee of Rhythm’s board of directors granted inducement equity grants covering an aggregate of 76,440 shares of its common stock to 16 new employees.

May 5, 2023
·
9 min read